Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Mitchell

Showing results (41-50 of 249) with videos related to

Pageof 25
Sort By:
Lancet (London, England)|July 26, 1997
Edinburgh doctor struck off because of clinical-trial fraudPeter Mitchell
Biochimica Et Biophysica Acta|November 16, 2011
Chemiosmotic coupling in oxidative and photosynthetic phosphorylation. 1966Peter Mitchell
Nature Biotechnology|February 3, 2004
Biotech holds steady in Q4Peter Mitchell
Nature Biotechnology|September 2, 2004
Cash-strapped biotechs find financing alternativePeter Mitchell
Nature Medicine|April 3, 2002
Charity's first move is drug investmentPeter Mitchell
Nature Biotechnology|July 13, 2010
Proteomics retrenchesPeter Mitchell
Nature Biotechnology|February 11, 2009
Venture capital shifts strategies, startups sufferPeter Mitchell
Nature Reviews. Drug Discovery|April 26, 2007
Price controls seen as key to Europe's drug innovations lagPeter Mitchell
Nature Biotechnology|January 10, 2009
Biotech sector ponders potential 'bloodbath'Peter Mitchell
Nature Biotechnology|April 9, 2008
US credit crunch impacts biotech across the globePeter Mitchell
Pageof 25

Showing results (41-50 of 249) with videos related to

Sort By:
Pageof 25
Lancet (London, England)|July 26, 1997
Edinburgh doctor struck off because of clinical-trial fraudPeter Mitchell
Biochimica Et Biophysica Acta|November 16, 2011
Chemiosmotic coupling in oxidative and photosynthetic phosphorylation. 1966Peter Mitchell
Nature Biotechnology|February 3, 2004
Biotech holds steady in Q4Peter Mitchell
Nature Biotechnology|September 2, 2004
Cash-strapped biotechs find financing alternativePeter Mitchell
Nature Medicine|April 3, 2002
Charity's first move is drug investmentPeter Mitchell
Nature Biotechnology|July 13, 2010
Proteomics retrenchesPeter Mitchell
Nature Biotechnology|February 11, 2009
Venture capital shifts strategies, startups sufferPeter Mitchell
Nature Reviews. Drug Discovery|April 26, 2007
Price controls seen as key to Europe's drug innovations lagPeter Mitchell
Nature Biotechnology|January 10, 2009
Biotech sector ponders potential 'bloodbath'Peter Mitchell
Nature Biotechnology|April 9, 2008
US credit crunch impacts biotech across the globePeter Mitchell
Pageof 25